# BullFrog AI Holdings, Inc.

BullFrog AI Holdings, Inc. is an Asset Manager.

## Overview

- **Organization type:** Asset Manager
- **Assets under management:** Undisclosed
- **Website:** bullfrogai.com
- **LinkedIn:** https://www.linkedin.com/company/bullfrogai

## Regulatory record

- **Reports private funds:** No

## About

BullFrog AI Holdings, Inc., listed on the Nasdaq in 2022, has not disclosed its founding year or founding principals publicly. The company's stated focus is on using artificial intelligence to analyze clinical and preclinical data for pharmaceutical and biotechnology partners, particularly in oncology and neurology. The firm's strategy revolves around a platform called bfLeap™, which applies machine learning to identify biomarkers and predict drug responses. Its geographic footprint is unclear from available records. No team size, additional offices, or adjacent vehicles have been confirmed. The most recent notable operational event was its Nasdaq listing in 2022 (per public filings, 2022). BullFrog AI's structural differentiator is its public listing, making it a rare publicly traded asset manager focused on AI-driven drug development. However, its lack of disclosed AUM, deployment, or principals limits visibility into its actual investment activities.

## Sectors

- AI/ML
- Healthcare Services

## Questions

### What is BullFrog AI's business model?

BullFrog AI describes itself as an AI-powered drug development company that uses its bfLeap™ platform to analyze clinical data for pharmaceutical partners. It does not appear to manage third-party capital or operate as a family office.

### Who are the principals leading BullFrog AI?

Public records do not clearly identify named principals or leadership beyond standard corporate filings. The firm's website and public disclosures have not highlighted investment professionals.

### What sectors does BullFrog AI focus on?

The firm targets the healthcare and life sciences sectors, with emphasis on oncology and neurology. It applies machine learning to clinical trial data to improve drug success rates.

### When was BullFrog AI founded and where is it headquartered?

The firm's founding year is not publicly available. It became a public company in 2022, but its headquarters location is not confirmed. Public filings and websites are sparse.

### Does BullFrog AI accept external investments?

As a publicly traded entity, any investor can purchase shares of BullFrog AI Holdings on the Nasdaq. However, it does not appear to raise dedicated investment funds from institutions or allocators.

## Related profiles

- [Creative Media & Community Trust Corp](https://altss.com/profile/creative-media-and-community-trust-corp)
- [Pharma-Bio Serv, Inc.](https://altss.com/profile/pharma-bio-serv-inc)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/bullfrog-ai-holdings-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology